Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Construction In Progress : ¥956.9 Mil (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co Construction In Progress?

Beijing Bohui Innovation Biotechnology Group Co's quarterly construction in progress increased from Sep. 2024 (¥913.8 Mil) to Dec. 2024 (¥933.1 Mil) and increased from Dec. 2024 (¥933.1 Mil) to Mar. 2025 (¥956.9 Mil).

Beijing Bohui Innovation Biotechnology Group Co's annual construction in progress increased from Dec. 2022 (¥809.7 Mil) to Dec. 2023 (¥888.4 Mil) and increased from Dec. 2023 (¥888.4 Mil) to Dec. 2024 (¥933.1 Mil).

Beijing Bohui Innovation Biotechnology Group Co Construction In Progress Historical Data

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Bohui Innovation Biotechnology Group Co Construction In Progress Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

274.88

629.95

809.66

888.36

933.12

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															901.77	928.48	913.75	933.12	956.85

Beijing Bohui Innovation Biotechnology Group Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Beijing Bohui Innovation Biotechnology Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097

Website

http://www.bohui-tech.com

Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.

Executives

Niu Shu Hui	Executives
Di Xiao Feng	Director
Yang Qi	Director
Lu Xin Qun	Directors, executives
Zhang Lei	Director
Wan Zhang Geng	Executives
Song Rui	Directors, executives

Beijing Bohui Innovation Biotechnology Group Co Headlines

No Headlines